297 studies found for:    HIV [CONDITION] AND ((anti-hiv OR antiretroviral) AND medicines) [TREATMENT] | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)
Conditions: Tuberculosis;   HIV
Interventions: Drug: 8 hourly LPV/r during TB treatment;   Drug: Nevirapine;   Drug: Lopinavir/Ritonavir
22 Unknown  A Pilot Study of Triple NtRTI/NsRTI Therapy in Antiretroviral Naive HIV-1 Infected Patients
Condition: HIV
Intervention: Drug: Zidovudine (drug)
23 Recruiting Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 28 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
Condition: HIV Infections
Interventions: Drug: Lamivudine/zidovudine;   Drug: Efavirenz;   Drug: Raltegravir
24 Recruiting Management of Participants With Low-level Persistent Viremia (ANRS 161 L-VIR)
Conditions: HIV-1 Infection;   Treatment Resistant Disorders;   Viremia
Interventions: Drug: Protease inhibitor;   Drug: Isentress® (raltegravir);   Other: Counseling arm
25 Recruiting Seek, Test, Treat Strategies for Vietnamese Drug Users: A Randomized Controlled Trial
Conditions: HIV;   Addiction
Intervention: Other: Integrated methadone and antiretroviral therapy (iMART) clinic
26 Unknown  Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: Raltegravir;   Drug: Atazanavir/Ritonavir
27 Recruiting Optimized Antiretroviral Therapy During Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1 Individuals
Condition: HIV
Intervention: Drug: Enfuvirtide
28 Recruiting DRV/r + RPV QD: Efficacy and Toxicity Reduction
Condition: Human Immunodeficiency Virus
Interventions: Drug: RPV + DRV/r;   Drug: continue the PI/r-containing HAART.
29 Recruiting Quantifying Drug Adherence and Drug Exposure to Antiretroviral Therapy
Condition: HIV/AIDS
Intervention:
30 Unknown  High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease
Conditions: HIV;   AIDS
Intervention: Drug: Kaletra (drug)
31 Unknown  Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: LPV/r;   Drug: Nucleoside Reverse Transcriptase Inhibitors;   Drug: PEG-IFNa 2a;   Drug: Ribavirin
32 Unknown  Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: LPV/r;   Drug: PEG-IFNa 2a;   Drug: Ribavirin;   Drug: NUCS
33 Recruiting Comparison of Virologic and Immunologic Responses to Raltegravir and Dolutegravir in the Gastrointestinal Tract of HIV-Positive Adults
Condition: Human Immunodeficiency Virus
Interventions: Drug: Raltegravir;   Drug: Dolutegravir;   Procedure: Colonoscopy with biopsy
34 Recruiting Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention
Condition: Reduction in Heavy Drinking in Patients With HIV
Interventions: Drug: Naltrexone;   Other: Placebo + Medication Management/Medication Coaching
35 Unknown  EARNEST Rifabutin Pharmacokinetics (PK) Substudy
Conditions: HIV;   Tuberculosis
Intervention: Drug: Rifabutin
36 Recruiting PrEP Demonstration Project (PRELUDE Study)
Condition: HIV
Intervention: Drug: emtricitabine/tenofovir disoproxil fumarate
37 Not yet recruiting IMPAACT P1106: Pharmacokinetic Characteristics of Antiretrovirals and Tuberculosis Medicines in Low Birth Weight Infants
Conditions: Low-Birth-Weight Infant;   Tuberculosis;   HIV
Intervention:
38 Not yet recruiting Drug Interaction Potential Between Dolutegravir and Simeprevir in HIV/HCV Seronegative Volunteers
Conditions: HIV;   Hepatitis C
Interventions: Drug: dolutegravir;   Drug: simeprevir
39 Not yet recruiting Evaluation of the Safety, Efficacy, and Pharmacokinetics of Intravenous Deferiprone in HIV-Positive Subjects
Condition: Asymptomatic HIV Infection
Interventions: Drug: Intravenous deferiprone;   Drug: Placebo
40 Unknown  HIV Antiretroviral Drugs and Metabolism
Condition: HIV Infections
Intervention: Drug: ritonavir, lopinavir/ritonavir, atazanavir/ritonavir, efavirenz

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years